QYOBO API1000 Price Index – 64% of Prices Dropped in 2024 

Amid ongoing shifts in the global pharmaceutical market — including increasing regulatory scrutiny, raw material shortages, and evolving geopolitical tensions — the industry continues to navigate a landscape of uncertainty. In 2024, global API prices have largely trended downward, with QYOBO’s platform tracking these changes for thousands of APIs, excipients, intermediates and chemicals. This analysis describes API price fluctuations, highlights shifts across therapeutic categories, and provides AI-driven price forecasts for the coming months.

API Market: 5-Year Trends in USDMF and CEP Approvals

The API market is evolving rapidly, with regulatory approvals on the rise and manufacturing shifting towards Asia. Over the past five years, USDMF and CEP approvals have grown significantly, reflecting increasing demand for APIs in key therapeutic areas. India and China have emerged as dominant players, reshaping the industry landscape. What do these trends mean for the future of pharmaceutical manufacturing? Explore our latest insights.